{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:07:42Z","timestamp":1792789662655,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.neuint.2022.105313","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T11:17:08Z","timestamp":1645615028000},"page":"105313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Transthyretin: Its function and amyloid formation"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6814-0582","authenticated-orcid":false,"given":"Mitsuharu","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.neuint.2022.105313_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2022.105313_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/31.5.6341455","article-title":"Localization of human prealbumin in choroid plexus epithelium","volume":"31","author":"Aleshire","year":"1983","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.neuint.2022.105313_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1006\/bbrc.2000.2554","article-title":"Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M","volume":"270","author":"Almeida","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2022.105313_bib5","first-page":"1","article-title":"Familial amyloidosis with polyneuropathy: a clinical study based onpatients living in northern Sweden","volume":"590","author":"Andersson","year":"1976","journal-title":"Acta Med. Scand. Suppl."},{"issue":"3","key":"10.1016\/j.neuint.2022.105313_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","article-title":"A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation","volume":"77","author":"Ando","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.neuint.2022.105313_bib7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archneur.62.7.1057","article-title":"Transthyretin-related familial amyloidotic polyneuropathy","volume":"62","author":"Ando","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2022.105313_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy: familial generalized amy-loidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105313_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archneur.1968.00470360015001","article-title":"Polyneurotic amyloidosis in a Japanese family","volume":"18","author":"Araki","year":"1968","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.neuint.2022.105313_bib10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","article-title":"Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?","volume":"108","author":"Aus dem Siepen","year":"2019","journal-title":"Clin. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neuint.2022.105313_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.neuint.2022.105313_bib13","article-title":"Tissue biopsy for the diagnosis of amyloidosis: experience from some centres","author":"Benson","year":"2021","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.1759","article-title":"Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology","volume":"206","author":"Bergstr\u00f6m","year":"2005","journal-title":"J. Pathol."},{"issue":"24","key":"10.1016\/j.neuint.2022.105313_bib15","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.neuint.2022.105313_bib16","doi-asserted-by":"crossref","first-page":"592644","DOI":"10.3389\/fnmol.2020.592644","article-title":"Modulation of the mechanisms driving transthyretin amyloidosis","volume":"13","author":"Bezerra","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"17","key":"10.1016\/j.neuint.2022.105313_bib17","doi-asserted-by":"crossref","first-page":"9488","DOI":"10.3390\/ijms22179488","article-title":"In vitro and in vivo effects of SerpinA1 on the modulation of transthyretin proteolysis","volume":"22","author":"Bezerra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2022.105313_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0022-2836(78)90368-6","article-title":"Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A","volume":"121","author":"Blake","year":"1978","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.neuint.2022.105313_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaccao.2021.07.002","article-title":"Genomic screening for pathogenic transthyretin variants finds evidence of underdiagnosed amyloid cardiomyopathy from health records","volume":"3","author":"Carry","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14756366.2020.1760262","article-title":"Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design","volume":"35","author":"Ciccone","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.neuint.2022.105313_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neuint.2022.105313_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human transthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"issue":"8","key":"10.1016\/j.neuint.2022.105313_bib23","doi-asserted-by":"crossref","first-page":"e2899","DOI":"10.1371\/journal.pone.0002899","article-title":"Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor","volume":"3","author":"Costa","year":"2008","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.neuint.2022.105313_bib24","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2019.17935","article-title":"Association of the V122I hereditary transthyretin amyloidosis genetic variant with heart failure among individuals of African or hispanic\/latino ancestry","volume":"322","author":"Damrauer","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ejhf.2027","article-title":"Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study","volume":"23","author":"Damy","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.neuint.2022.105313_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0304-3940(86)90037-6","article-title":"High levels of messenger RNA for transthyretin (prealbumin) in human choroid plexus","volume":"66","author":"Dickson","year":"1986","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.neuint.2022.105313_bib27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/acn3.51328","article-title":"Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study","volume":"8","author":"Du","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.neuint.2022.105313_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/joim.13222","article-title":"Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis","volume":"289","author":"Eldhagen","year":"2021","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.neuint.2022.105313_bib29","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver transplantation for hereditary transthyretin amyloidosis: after 20 Years still the best therapeutic alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.neuint.2022.105313_bib30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/bi00673a014","article-title":"Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid","volume":"14","author":"Ferguson","year":"1975","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2022.105313_bib31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0021-9258(19)57418-X","article-title":"Structure and expression of the rat transthyretin (prealbumin) gene","volume":"263","author":"Fung","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.neuint.2022.105313_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"38","key":"10.1016\/j.neuint.2022.105313_bib33","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.neuint.2022.105313_bib34","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1016\/S0021-9258(19)43449-2","article-title":"Conformational changes following interaction between retinol isomers and human retinol-binding protein and between the retinol-binding protein and prealbumin","volume":"248","author":"Heller","year":"1973","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2022.105313_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/13506129.2012.670813","article-title":"Regional differences and similarities of FAP in Sweden","volume":"19","author":"Hellman","year":"2012","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/13506129.2016.1148025","article-title":"Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin","volume":"23","author":"Higaki","year":"2016","journal-title":"Amyloid"},{"issue":"48","key":"10.1016\/j.neuint.2022.105313_bib37","doi-asserted-by":"crossref","first-page":"25096","DOI":"10.1074\/jbc.M116.738138","article-title":"Novel antibody for the treatment of transthyretin amyloidosis","volume":"291","author":"Hosoi","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib39","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1038\/s41467-021-27481-4","article-title":"Structural basis for transthyretin amyloid formation in vitreous body of the eye","volume":"12","author":"Iakovleva","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neuint.2022.105313_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/13506129.2013.797890","article-title":"Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis","volume":"20","author":"Ihse","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.neuint.2022.105313_bib41","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1515\/CCLM.2002.222","article-title":"Significance of transthyretin in protein metabolism","volume":"40","author":"Ingenbleek","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.neuint.2022.105313_bib42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3945\/an.115.008508","article-title":"Plasma transthyretin as a biomarker of lean body mass and catabolic states","volume":"6","author":"Ingenbleek","year":"2015","journal-title":"Adv Nutr"},{"issue":"4","key":"10.1016\/j.neuint.2022.105313_bib43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/nu11040895","article-title":"Plasma transthyretin as A biomarker of sarcopenia in elderly subjects","volume":"11","author":"Ingenbleek","year":"2019","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.neuint.2022.105313_bib44","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1167\/iovs.13-12245","article-title":"Elevated levels of multiple biomarkers of Alzheimer's disease in the aqueous humor of eyes with open-angle glaucoma","volume":"54","author":"Inoue","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuint.2022.105313_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00493004","article-title":"In situ localization of transthyretin-mRNA in the adult human liver, choroid plexus and pancreatic islets and in endocrine tumours of the pancreas and gut","volume":"91","author":"Jacobsson","year":"1989","journal-title":"Histochemistry"},{"issue":"2\u20133","key":"10.1016\/j.neuint.2022.105313_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug","volume":"421","author":"Johnson","year":"2012","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.neuint.2022.105313_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jacc.2019.03.012","article-title":"Transthyretin stabilization by AG10 in symptomatic transthyretin amyloid cardiomyopathy","volume":"74","author":"Judge","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.neuint.2022.105313_bib48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI101335","article-title":"An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins","volume":"21","author":"Kabat","year":"1942","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2022.105313_bib49","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1172\/JCI105889","article-title":"Retinol-binding protein: the transport protein for vitamin A in human plasma","volume":"47","author":"Kanai","year":"1968","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2022.105313_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.exer.2005.02.003","article-title":"Transthyretin synthesis in rabbit ciliary pigment epithelium","volume":"81","author":"Kawaji","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"15","key":"10.1016\/j.neuint.2022.105313_bib51","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1039\/C9CS00199A","article-title":"Half a century of amyloids: past, present and future","volume":"49","author":"Ke","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.neuint.2022.105313_bib52","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1253\/circj.CJ-20-0110","article-title":"Japanese circulation society joint working group. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis","volume":"84","author":"Kitaoka","year":"2020","journal-title":"Circ. J."},{"issue":"11","key":"10.1016\/j.neuint.2022.105313_bib53","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","article-title":"Study Group for Hereditary Neuropathy in Japan. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form","volume":"59","author":"Koike","year":"2002","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000132966.36437.12","article-title":"Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy","volume":"63","author":"Koike","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp-2011-301299","article-title":"Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas","volume":"83","author":"Koike","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"20","key":"10.1016\/j.neuint.2022.105313_bib56","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2022.105313_bib57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/path.1711460205","article-title":"Immunolocalization of prealbumin: distribution in normal human tissue","volume":"146","author":"Liddle","year":"1985","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/BJ20082090","article-title":"Substrate specificity of transthyretin: identification of natural substrates in the nervous system","volume":"419","author":"Liz","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2022.105313_bib59","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1016\/S0021-9258(18)68346-2","article-title":"Plasma transthyretin. Tissue sites of degradation and turnover in the rat","volume":"263","author":"Makover","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.neuint.2022.105313_bib60","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15252\/emmm.201505357","article-title":"A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis","volume":"7","author":"Marcoux","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"THAOS investigators. Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (transthyretin amyloid outcome survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.neuint.2022.105313_bib62","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib63","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1038\/s41467-021-23274-x","article-title":"A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells","volume":"12","author":"Michalon","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2022.105313_bib64","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.7754382","article-title":"Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein","volume":"268","author":"Monaco","year":"1995","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13506129.2015.1135792","article-title":"Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis","volume":"23","author":"Nakagawa","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.neuint.2022.105313_bib66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/endo-63-2-256","article-title":"Pre-albumin: a thyroxinebinding protein of human plasma","volume":"63","author":"Ngbar","year":"1958","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.neuint.2022.105313_bib68","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1136\/jmg.2003.014803","article-title":"Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy","volume":"41","author":"Ohmori","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuint.2022.105313_bib69","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/bi00173a029","article-title":"Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium","volume":"33","author":"Ong","year":"1994","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib70","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s42003-020-01493-0","article-title":"A serine protease secreted from Bacillus subtilis cleaves human plasma transthyretin to generate an amyloidogenic fragment","volume":"3","author":"Peterle","year":"2020","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.neuint.2022.105313_bib71","first-page":"189","article-title":"Current review of leptomeningeal amyloidosis associated with transthyretin mutations","volume":"26","author":"Qin","year":"2021","journal-title":"Neurol."},{"issue":"46","key":"10.1016\/j.neuint.2022.105313_bib72","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.1074\/jbc.274.46.32943","article-title":"The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis","volume":"274","author":"Quintas","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.neuint.2022.105313_bib73","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib74","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"issue":"2 Pt 2","key":"10.1016\/j.neuint.2022.105313_bib75","first-page":"R338","article-title":"Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus","volume":"258","author":"Schreiber","year":"1990","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.neuint.2022.105313_bib76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1006\/jmbi.2000.4415","article-title":"Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution","volume":"306","author":"Sebasti\u00e3o","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuint.2022.105313_bib77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0021-9258(18)72655-0","article-title":"Electrophoretic study of the blood. protein response in tuberculosis","volume":"143","author":"Seibert","year":"1942","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.neuint.2022.105313_bib78","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.humpath.2011.03.004","article-title":"High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly","volume":"42","author":"Sekijima","year":"2011","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.neuint.2022.105313_bib79","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.0000000000003001","article-title":"Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis","volume":"87","author":"Sekijima","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13023-017-0726-x","article-title":"Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm","volume":"13","author":"Sekijima","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.neuint.2022.105313_bib81","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.63.4.506","article-title":"Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease","volume":"63","author":"Serot","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuint.2022.105313_bib82","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1172\/JCI106741","article-title":"The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma","volume":"50","author":"Smith","year":"1971","journal-title":"J. Clin. Invest."},{"issue":"49","key":"10.1016\/j.neuint.2022.105313_bib83","doi-asserted-by":"crossref","first-page":"38176","DOI":"10.1074\/jbc.M002886200","article-title":"Evidence for the role of megalin in renal uptake of transthyretin","volume":"275","author":"Sousa","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.neuint.2022.105313_bib84","doi-asserted-by":"crossref","first-page":"14420","DOI":"10.1074\/jbc.M010869200","article-title":"Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor","volume":"276","author":"Sousa","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.neuint.2022.105313_bib85","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.humpath.2010.11.017","article-title":"Wild-type transthyretin-derived amyloidosis in various ligaments and tendons","volume":"42","author":"Sueyoshi","year":"2011","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.neuint.2022.105313_bib86","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/joim.12585","article-title":"One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition","volume":"281","author":"Suhr","year":"2017","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neuint.2022.105313_bib87","doi-asserted-by":"crossref","first-page":"101388","DOI":"10.1016\/j.arr.2021.101388","article-title":"Age-related amyloidosis outside the brain: a state-of-the-art review","volume":"70","author":"Tasaki","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.neuint.2022.105313_bib88","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0006-291X(83)80224-1","article-title":"Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type)","volume":"116","author":"Tawara","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2022.105313_bib89","doi-asserted-by":"crossref","DOI":"10.1006\/bbrc.1999.1514","article-title":"A novel compound heterozygote (FAP ATTR Arg104His\/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels","author":"Terazaki","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.neuint.2022.105313_bib90","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/modpathol.2011.117","article-title":"Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study","volume":"24","author":"Ueda","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.neuint.2022.105313_bib91","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-9158-3-19","article-title":"Recent advances in transthyretin amyloidosis therapy","volume":"3","author":"Ueda","year":"2014","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.neuint.2022.105313_bib92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/13506129.2018.1531842","article-title":"Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan","volume":"25","author":"Ueda","year":"2018","journal-title":"Amyloid"},{"issue":"29","key":"10.1016\/j.neuint.2022.105313_bib93","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1074\/jbc.RA119.007851","article-title":"A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH","volume":"294","author":"Ueda","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib94","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1074\/jbc.M008091200","article-title":"Biochemical basis for depressed serum retinol levels in transthyretin-deficient mice","volume":"276","author":"van Bennekum","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2022.105313_bib95","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1016\/S0021-9258(19)43720-4","article-title":"The interaction of human plasma retinol-binding protein and prealbumin","volume":"248","author":"van Jaarsveld","year":"1973","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/bmc-2013-0038","article-title":"Transthyretin: a multifaceted protein","volume":"5","author":"Vieira","year":"2014","journal-title":"Biomol. Concepts"},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib97","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40120-021-00258-z","article-title":"THAOS investigators. Characteristics of patients with late- vs. Early-onset Val30Met transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey (THAOS)","volume":"10","author":"Waddington-Cruz","year":"2021","journal-title":"Neurol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2022.105313_bib98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/13506129.2003.12088568","article-title":"Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations","volume":"10","author":"Westermark","year":"2003","journal-title":"Amyloid"},{"issue":"9","key":"10.1016\/j.neuint.2022.105313_bib99","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/WNL.0b013e318248df18","article-title":"Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy","volume":"78","author":"Yamashita","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00415-017-8640-7","article-title":"Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan","volume":"265","author":"Yamashita","year":"2018","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2022.105313_bib101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/modpathol.2014.102","article-title":"Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis","volume":"28","author":"Yanagisawa","year":"2015","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.neuint.2022.105313_bib102","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/13506129.2015.1115758","article-title":"Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid","volume":"23","author":"Yanagisawa","year":"2016","journal-title":"Amyloid"},{"issue":"Pt 4","key":"10.1016\/j.neuint.2022.105313_bib103","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1469-1809.2008.00439.x","article-title":"On the origin of the transthyretin Val30Met familial amyloid polyneuropathy","volume":"72","author":"Zaros","year":"2008","journal-title":"Ann. Hum. Genet."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:58:27Z","timestamp":1759312707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018622000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":102,"alternative-id":["S0197018622000389"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105313","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transthyretin: Its function and amyloid formation","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105313"}}